These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 2555723)
21. Meiosis reinitiation of mussel oocytes involves L-type voltage-gated calcium channel. Tomkowiak M; Guerrier P; Krantic S J Cell Biochem; 1997 Jan; 64(1):152-60. PubMed ID: 9015763 [TBL] [Abstract][Full Text] [Related]
22. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium. Ferry DR; Kaumann AJ Br J Pharmacol; 1987 Mar; 90(3):447-57. PubMed ID: 2436700 [TBL] [Abstract][Full Text] [Related]
23. The pharmacological properties of the peptide, endothelin. Eglen RM; Michel AD; Sharif NA; Swank SR; Whiting RL Br J Pharmacol; 1989 Aug; 97(4):1297-307. PubMed ID: 2551446 [TBL] [Abstract][Full Text] [Related]
24. Maitotoxin induces a calcium-dependent membrane depolarization in GH4C1 pituitary cells via activation of type L voltage-dependent calcium channels. Xi D; Van Dolah FM; Ramsdell JS J Biol Chem; 1992 Dec; 267(35):25025-31. PubMed ID: 1334077 [TBL] [Abstract][Full Text] [Related]
25. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries. Müller-Schweinitzer E; Neumann P J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932 [TBL] [Abstract][Full Text] [Related]
26. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey. Nakajima M; Adachi I; Ueda M Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of vascular relaxation by thaligrisine: functional and binding assays. Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849 [TBL] [Abstract][Full Text] [Related]
29. KCl-induced insulin secretion from RINm5F cells is mediated through Ca2+ influx along L-type Ca2+ channels. Roenfeldt M; Safayhi H; Ammon HP Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):527-31. PubMed ID: 1335126 [TBL] [Abstract][Full Text] [Related]
30. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma. Bevilacqua M; Vago T; Norbiato G Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633 [TBL] [Abstract][Full Text] [Related]
32. Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries. Yamada S; Uchida S; Naito T; Urayama A; Kimura R; Murakami Y; Matsumoto K; Watanabe H Life Sci; 2000 Feb; 66(14):1351-7. PubMed ID: 10755471 [TBL] [Abstract][Full Text] [Related]
33. Purified calcium channels have three allosterically coupled drug receptors. Striessnig J; Goll A; Moosburger K; Glossmann H FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161 [TBL] [Abstract][Full Text] [Related]
34. The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissues. Kwon YW; Zhong Q; Wei XY; Zheng W; Triggle DJ Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):128-36. PubMed ID: 2156174 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of field stimulation-evoked relaxations in rat oesophageal smooth muscle by the calcium antagonist PN 200-110. Akbarali HI; Bieger D; Triggle CR Br J Pharmacol; 1988 Oct; 95(2):512-8. PubMed ID: 2976289 [TBL] [Abstract][Full Text] [Related]
36. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284 [TBL] [Abstract][Full Text] [Related]
37. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. Dubé GP; Baik YH; Schwartz A J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094 [TBL] [Abstract][Full Text] [Related]
38. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes. Carvalho CA; Coutinho OP; Carvalho AP J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061 [TBL] [Abstract][Full Text] [Related]
39. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307 [TBL] [Abstract][Full Text] [Related]
40. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals. Flink MT; Atchison WD J Pharmacol Exp Ther; 2003 May; 305(2):646-52. PubMed ID: 12606686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]